Achmea Investment Management B.V. Increases Stock Position in The Clorox Company (NYSE:CLX)

Achmea Investment Management B.V. grew its stake in shares of The Clorox Company (NYSE:CLX) by 3.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 33,538 shares of the company’s stock after buying an additional 1,201 shares during the period. Achmea Investment Management B.V.’s holdings in Clorox were worth $4,577,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in CLX. Core Wealth Advisors Inc. acquired a new position in shares of Clorox during the 4th quarter valued at $29,000. Innealta Capital LLC acquired a new position in shares of Clorox during the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC lifted its holdings in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. GoalVest Advisory LLC acquired a new position in shares of Clorox during the 1st quarter valued at $31,000. Finally, First Foundation Advisors acquired a new position in shares of Clorox during the 1st quarter valued at $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.51% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $164.98 on Friday. The firm has a market cap of $20.49 billion, a PE ratio of 85.48, a price-to-earnings-growth ratio of 3.34 and a beta of 0.40. The firm’s 50-day simple moving average is $145.50 and its 200-day simple moving average is $143.27. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $167.75.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Equities analysts forecast that The Clorox Company will post 6.56 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. The ex-dividend date of this dividend was Tuesday, August 13th. This is an increase from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio is currently 252.85%.

Analyst Ratings Changes

Several equities analysts recently weighed in on CLX shares. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. DA Davidson reiterated a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. TD Cowen started coverage on shares of Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. Wells Fargo & Company cut their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Six research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $143.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.